Esophageal impedance baseline in infants with bronchopulmonary dysplasia: A pilot study

Stefano Nobile1, Paolo Marchionni2, Fabio Meneghin3

  • 1Department of Woman, Child and Public Health, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.

Pediatric Pulmonology
|November 16, 2021
PubMed

Insights

Preterm infants with bronchopulmonary dysplasia (BPD) show lower esophageal impedance baseline values (BI), indicating inflammation. BPD and chronological age are key predictors of BI in these vulnerable infants.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Respiratory Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease in preterm infants.
  • Gastroesophageal reflux (GER) is a common complication associated with BPD.
  • Esophageal impedance baseline values (BI) can reflect esophageal mucosal inflammation.

Purpose of the Study:

  • To compare BI levels in preterm infants with and without BPD.
  • To identify predictors of BI in preterm infants, particularly those with BPD.
  • To investigate the relationship between BPD, GER, and esophageal inflammation.

Main Methods:

  • Retrospective pilot study of infants born <32 weeks gestational age (GA).
  • Esophageal multichannel intraluminal impedance (MII)-pH monitoring was performed.
  • Univariate and multivariate analyses were used to compare groups and identify predictors.

Main Results:

  • Infants with BPD had significantly lower BI compared to non-BPD infants (2050 vs. 2574 ohms).
  • BPD was associated with lower BI (B = -793.4, p < 0.001) in multivariate analysis.
  • Increasing chronological age was positively associated with BI (B = 9.3, p = 0.013).

Conclusions:

  • Preterm infants with BPD exhibit significantly lower esophageal BI, suggesting increased mucosal inflammation.
  • Both BPD and chronological age are significant predictors of BI.
  • In the most immature infants (<29 weeks GA), BPD was the sole predictor of lower BI.
Abstract